Đang chuẩn bị liên kết để tải về tài liệu:
A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer and is notorious for its resistance to both chemotherapy and small-molecule inhibitor targeted therapies. Subcellular targeted cancer therapy may thwart the resistance to produce a substantial effect. |

TÀI LIỆU LIÊN QUAN

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ ETS-1 signaling pathway

So sánh kết quả điều trị phác đồ Navelbin cisplatin và Paclitaxel cisplatin trong ung thư phổi không tế bào nhỏ giai đoạn IV

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer

Hematological alterations in cisplatin induced toxicity in rats and its amelioration by Andrographis paniculata

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer

A novel circular RNA hsa_circRNA_103809/ miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC)

Tác dụng không mong muốn phác đồ Cisplatin-etoposide trên bệnh nhân ung thư phổi thần kinh nội tiết tế bào lớn giai đoạn muộn

Novel amphiphilic heparin-pluronic P123 copolymers exhibiting a great potential for Cisplatin delivery

Summary of Material science doctoral thesis: Improving the effective delivery of cisplatin anti cancer drug of dendrimer nanocarrier

Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failure